Cart (0)

Your Cart is Empty

90 Day Money Back Guarantee

The Silent Threat of Statins and GLP-1s

The Silent Threat of Statins and GLP-1s

Statins are currently being used by millions of Americans to reduce cholesterol and to prevent heart disease. A recent study reveals that statins may reduce circulating GLP-1 levels, potentially disrupting metabolism, increasing insulin resistance, and elevating blood sugar. This interference affects GLP-1, the hormone mimicked by weight-loss drugs like Ozempic, highlighting an overlooked metabolic impact.

GLP-1 is crucial for blood sugar control, boosting insulin release and supporting glucose balance. Lower GLP-1 levels can disrupt these processes, causing insulin resistance and elevated blood sugar. Taking a statin alongside a medication like Ozempic may diminish some of its intended effects, especially those related to managing blood sugar.

The study consisted of 30 participants, taking the drug atorvastatin. They were monitored for four months with various controls. While cholesterol levels dropped as anticipated, blood sugar slightly increased, insulin resistance worsened, and GLP-1 levels decreased by nearly 50%.

The study revealed that statins modify the gut microbiome, particularly reducing Clostridium bacteria, which produce UDCA, a bile acid that supports GLP-1 production. With reduced microbes, UDCA levels dropped, leading to lower GLP-1. Essentially, statins disrupted a gut microbial pathway critical for blood sugar regulation.

Many doctors prescribe statins without discussing their impact on insulin resistance or overall metabolic health. For patients managing cholesterol and blood sugar, this overlooked connection is vital. 

Lifestyle interventions are indeed critical as a first-line approach to support and maintain metabolic health, especially for individuals on statins. Prioritizing lifestyle changes can enhance the effectiveness of statins, potentially reduce reliance on medication, and improve overall health.

To view the original scientific study click below:
Statins aggravate insulin resistance through reduced blood glucagon-like peptide-1 levels in a microbiota-dependent manner



Also in Articles

Diversify Your Exercise to Add Years to Your Life
Diversify Your Exercise to Add Years to Your Life

Consistent exercise is a major driver of longevity, working alongside good nutrition and emotional balance.Whether it’s lifting, running, aerobic, yoga, or something else, every exercise type leaves its own signature on your health and body. Movement is a key ingredient in living longer and thriving.

Read More
New Research Warns of Vaping's Lung Risks
New Research Warns of Vaping's Lung Risks

When e-cigarettes first appeared on the market, they were heavily promoted as a safer option for adult smokers trying to quit traditional tobacco. It soon became clear, however, that the nicotine-laden e-liquid used in vaping devices is highly addictive. The full mid- and long-term health effects of vaping are only now beginning to come into focus.

Read More
Depression Linked to Premature Brain Aging
Depression Linked to Premature Brain Aging

A recent study finds that people with major depressive disorder have brains that seem markedly older than their chronological age, connecting mental health with accelerated brain aging. While aging occurs naturally, mounting research suggests depression may speed up specific brain aging processes. 

Read More

Stem Cell and Anti-Aging Breakthroughs